Apparatus for eye tracking

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Digilens, Inc. patent solves the following problem:

This invention relates to an eye tracking sensor, and especially with an eye tracker to use electricity switchable networks.

Our analysis of this patent is as follows:

Digilens, Inc.’s patent US 9456744 B2 deals with Apparatus for eye tracking.
An eye tracker with a waveguide for propagating light to light to one eye and spread the light reflected from at least one face in one eye, a light source optically coupled to the waveguide and a detector optically coupled to the waveguide. Throw in the waveguide is at least one grating plate deflecting the light shining into the eye by a first waveguide path and deflecting the light to the detector by a second waveguide path.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Shaped support features for footwear ground-engaging members

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Nike, Inc. patent solves the following problem:

It is useful, when participating in various activities, with footwear that provides traction and stability on the surface on the activities taking place. Therefore, only the structure of the article of footwear developed in traction systems include ground engaging members to provide traction on a variety of surfaces. included in the sample cleated shoes for playing outside, like soccer, football, and baseball.

Our analysis of this patent is as follows:

Nike, Inc.’s patent US 9456659 B2 deals with Shaped support features for footwear ground-engaging members.
The present disclosure is directed to an article of footwear including a surface configured to receive a foot and a sole component fixedly attached to a lower portion of the upper. The only component may include a baseplate with a lower face and at least a first earth had members come substantially down from the lower face of the baseplate, and a former member the elongate support extending substantially downward from the lower face of the baseplate, abutting the first member country participating in a side to side, and extending horizontally from the side of the first member country participating. The first support member may have a lower face facing a first portion and a second portion, wherein each of the first part and the second part angled in different non -pinahigda orientation.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Vascular closure methods and apparatuses

File for Quick & Easy Patent Protection with PowerPatent.

The Abbott Vascular Inc. patent solves the following problem:

This application is related to US provisional application 60 / 711,279, filed August 25, 2005, and US utility application Ser. No. 11 / 316,775, filed December 23, 2005, each of which is incorporated here by reference. During angiography and related procedures, catheter inserted through an incision or puncture in the skin and underlying tissues to access a vein or artery, usually in the groin, neck, or subclavian places patients. catheter can be inserted through a puncture in the blood vessel and guided to the desired site to perform interventional procedures such as angiography, angioplasty, plaque removal, and infusion of a therapeutic substance. After the procedure is completed and the catheter is removed from the patient, the access hole should be closed to prevent massive bleeding. It is conventionally achieved by applying pressure on the blood vessels in the hand and then by applying a pressure bandage, compressive weight or clamp device. With conventional methods, the rate of post-puncture hemorrhage is high, which causes considerable complications. It complication exacerbated by the concomitant use of anticoagulant medications such as heparin or warfarin and by antiplatelet drugs, often used to treat vascular disease.

Our analysis of this patent is as follows:

Abbott Vascular Inc.’s patent US 9456811 B2 deals with Vascular closure methods and apparatuses.
A vascular closure device consists of a sheath-delivered cincture or cord-like device or knot comprising suture, wire, or other suitable material, are placed on the outer face of a puncture wound and shut. The vascular closure cincture delivered in a sheath, and after the closing left living on the outer surface of a tissue puncture wounds.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Household appliance for ironing with a filter for retaining mineral particles carried by the steam

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Seb S.A. patent solves the following problem:

Our analysis of this patent is as follows:

Seb S.A.’s patent US 9457305 B2 deals with Household appliance for ironing with a filter for retaining mineral particles carried by the steam.
Iron comprising a steam generator connected to the steam outlet hole in a steam conduit with at least one filter for retaining the mineral particles carried in steam, where the steam channel has a mineral deposit collection hole with a mineral deposit removal orifice closed by a detachable plug which is accessible from the outside of the iron, and where the filter can be detached from the iron by mineral deposit removal orifice.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Method and composition for sterilization of a polymerizable monomer

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Heraeus Medical Gmbh patent solves the following problem:

The invention relates to a method for the sterilization of a polymerizable monomer, in particular the sterilization of a monomer for radical polymerization. The invention also relates to mixtures containing a polymerizable monomer, in particular a monomer for radical polymerization, a kit for the production of bone cement containing one of these mixtures, and a bone cement paste consisting of one of these mixtures.

Our analysis of this patent is as follows:

Heraeus Medical Gmbh’s patent US 9457110 B2 deals with Method and composition for sterilization of a polymerizable monomer.
A procedure provided for sterilization in a polymerizable monomer, the mixture comprising at least the polymerizable monomer, a compound (a), and a compound (b). Compound (a) is selected from the group of compounds (A1), compounds (a2), and the compounds (A3), which compounds (A1) represented by the general formula (I): wherein R1, R2, P3, and R4, independently of one another, represent a substituted alkyl residue, a non-substituted alkyl residue, a halogen, a nitro group, or a cyano group; compounds (a2) selected from the group of dimers of the compounds (A1); and compounds (A3) is selected from the group of dialkyldicarbonates. Compound (b) is selected from the group of water and alcohol.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Merchandiser

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Target Brands, Inc. patent solves the following problem:

A retail store used gondola display units to organize and present merchandise to customers for purchase. A gondola display unit includes at least one base deck, a pair of pillars and a rear wall that vertically extends upward from the base deck and located between the pair of columns. The gondola display unit further includes display shelves, peg hooks, horizontal slats and others supported by the pair of columns and the back panel and presenting merchandise.

Our analysis of this patent is as follows:

Target Brands, Inc.’s patent US 9456708 B2 deals with Merchandiser.
A display apparatus includes a merchandiser box and an adapter. The merchandiser has an outer face down and an inner space defined by a back, a pair of sides, an inner bottom surface, a top and a front of a window. The empty space staff and merchandise presentation. The adapter couple behind the merchandiser box to a wall in a display instrument as external lower face of the box merchandiser revealed by general. adapter includes at least a space for receiving at least one was an exception back merchandiser box.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Method and system for identifying vehicle collisions using sensor data

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The State Farm Mutual Automobile Insurance Company patent solves the following problem:

Now, vehicle collisions can be identified by the driver, passengers and witnesses who saw or was involved in the collision. However, such collisions are not recognized and reported in real-time, for the driver, passengers and witnesses involved in the collision will be capacity or unwilling to report the collision. In addition, an assessment of a vehicle collision can be performed after the collision occurs, and may be based on reports of vehicle damage and / or reports to the police.

Our analysis of this patent is as follows:

State Farm Mutual Automobile Insurance Company’s patent US 9457754 B1 deals with Method and system for identifying vehicle collisions using sensor data.
A method and system for identifying car collisions in real-time or at least near real-time based on statistical data collected from the previous car collisions. portable computing device to a user obtains sensor data from the sensor to the portable computing device and compare the sensor data into a statistical model indicates a vehicle collision. As indicated in portable computing device in a vehicle collision based on comparison, notifications can be sent to emergency contacts and / or emergency personnel to provide assistance to the user.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Recyclable indicator tape for sterilization

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Avent, Inc. patent solves the following problem:

Our analysis of this patent is as follows:

Avent, Inc.’s patent US 9457115 B2 deals with Recyclable indicator tape for sterilization.
There was a sterilization indicating tape with a breathable and liquid impervious film, where the tape was published in a sterilization indicator ink. tape is compatible with a polymer wrap for recycling. tape used to hold a wrapped package closed so that it sterilized and stored. The ink changes color over sterilization to show the user that the package under sterilization. tape desirably made from the same or similar polymer wrap polymer to recycle them together.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Method for inducing cell death in acute lymphoblastic leukemic system cells

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Cantargia Ab patent solves the following problem:

Chronic myeloid leukemia (CML) is the first human neoplasm associated with a recurrent genetic aberration; Philadelphia (Ph) chromosome, formed by a corresponding transition between chromosome 9 and 22, giving rise to a constitutively activated tyrosine kinase BCR / ABL11. In CML, Ph chromosome is believed to originate from a hematopoietic stem cell (HSC) as it clonally found in malignant myeloid cells and non-malignant lymphoid cells2. The Ph chromosome is found in a part of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). CML composed of heterogeneous cell in various stages maturation maintained by a small number of cells, called CML stem cells, sharing the capacity of self-renewal of normal HSC3 . This shows that CML stem cells at least partially resistant to current treatments tyrosine kinase inhibitors4,5, despite clinical success demonstrated a suppressive rather than curative effects of this disease. Therefore, recognition of a way to efficiently target CML stem cells very attractive to achieve a permanent cure for the disease. Such a strategy to identify a target in CML stem cells provide a novel means to eliminate CML stem cells. Encouraging reports its direction described in the related disorder acute myeloid leukemia (AML), where the antibody target CD123, CXCR4, CD44 or CD47 in AML stem cells to express anti-leukemic effects in animal AML models6-9. Furthermore, AML stem cell associated antigens CD96 and CLL-1 identified10,11, providing additional targeted candidates of this disease. Surprisingly, even in one of the most studied neoplasms of all time, called a cancer stem cell disorder, no cell surface biomarker so far recognized the CML that allows a future separation of CML stem cells in normal HSCs, when the rare CD34 + CD38 cell population12,13. Recognizing that a biomarker tool to characterize the CML stem cells, but can also be used for new treatment developments and for tracking therapeutic effects of ancient CML cells during treatment.

Our analysis of this patent is as follows:

Cantargia Ab’s patent US 9458237 B2 deals with Method for inducing cell death in acute lymphoblastic leukemic system cells.
The present invention provides agents comprising or consisting of a binding moiety with specificity for interleukin-1 receptor accessory protein (IL1RAP) for use in inducing cell death and / or inhibiting the growth and / or proliferation pathological cells in the stem and / or progenitor cells associated with a neoplastic hematologic disorder, in which the cells expressing IL1RAP. A related aspect the invention provides agents comprising or consisting of a binding moiety with specificity for interleukin-1 receptor accessory protein (IL1RAP) for use in identifying pathological stem cells and / or fathers cells associated with a neoplastic hematologic disorder, in which the cells expressing IL1RAP. Moreover given the medicine composition containing the agents to devise methods of using the same.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Trolley for transporting individuals of limited capacity in sedentary position on chair

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The David Mizrachi patent solves the following problem:

A wheelchair is a wheeled mobility device user is sitting. device is propelled either manually (by turning the wheels by hand) or through various automated systems. Wheelchair used in men for whom walking is difficult or impossible due to illness (physiological or physical), injury, or disability.

Our analysis of this patent is as follows:

David Mizrachi’s patent US 9456941 B2 deals with Trolley for transporting individuals of limited capacity in sedentary position on chair.
A trolley for transporting individuals with limited capacity in an active position in a chair exposed. The aforesaid trolley belonging to (a) a bearing structure and (b) at least three wheels rotatably structures within a perimeter. The bearing structure configured to releasably fixating the legs of the chair as the chair is reversibly mountable carrying structure.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.